[1]
2026. Socio-Gerontological Perspectives on Disease-Modifying Alzheimer’s Therapies (Lecanemab): A Delphi Study in Central Europe. Journal of Health and Rehabilitation Sciences. 5, 1 (May 2026), 1–9. DOI:https://doi.org/10.33700/jhrs.5.1.222.